25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

Argent Biopharma Limited
Buy, Hold or Sell?

Let's analyze Argent Biopharma Limited together

I guess you are interested in Argent Biopharma Limited. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Argent Biopharma Limited. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Argent Biopharma Limited

I send you an email if I find something interesting about Argent Biopharma Limited.

1. Quick Overview

1.1. Quick analysis of Argent Biopharma Limited (30 sec.)










1.2. What can you expect buying and holding a share of Argent Biopharma Limited? (30 sec.)

How much money do you get?

How much money do you get?
A$0.00
When do you have the money?
1 year
How often do you get paid?
40.0%

What is your share worth?

Current worth
A$-0.11
Expected worth in 1 year
A$0.06
How sure are you?
60.0%

+ What do you gain per year?

Total Gains per Share
A$0.16
Return On Investment
65.1%

For what price can you sell your share?

Current Price per Share
A$0.25
Expected price per share
A$0.15 - A$0.295
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Argent Biopharma Limited (5 min.)




Live pricePrice per Share (EOD)
A$0.25
Intrinsic Value Per Share
A$-2.92 - A$-1.18
Total Value Per Share
A$-3.02 - A$-1.28

2.2. Growth of Argent Biopharma Limited (5 min.)




Is Argent Biopharma Limited growing?

Current yearPrevious yearGrowGrow %
How rich?-$3.7m-$5.2m$1.4m37.9%

How much money is Argent Biopharma Limited making?

Current yearPrevious yearGrowGrow %
Making money-$11.4m-$13.5m$2.1m18.8%
Net Profit Margin-1,967.3%-614.7%--

How much money comes from the company's main activities?

2.3. Financial Health of Argent Biopharma Limited (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Argent Biopharma Limited?

Welcome investor! Argent Biopharma Limited's management wants to use your money to grow the business. In return you get a share of Argent Biopharma Limited.

First you should know what it really means to hold a share of Argent Biopharma Limited. And how you can make/lose money.

Speculation

The Price per Share of Argent Biopharma Limited is A$0.25. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Argent Biopharma Limited.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Argent Biopharma Limited, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is A$-0.11. Based on the TTM, the Book Value Change Per Share is A$0.04 per quarter. Based on the YOY, the Book Value Change Per Share is A$-0.24 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is A$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Argent Biopharma Limited.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 A$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per ShareA$% of Price per Share
Usd Eps-0.21-84.0%-0.21-84.0%-0.25-99.8%-0.22-86.6%-0.15-60.1%
Usd Book Value Change Per Share0.0310.6%0.0310.6%-0.16-63.3%-0.04-15.9%-0.01-5.0%
Usd Dividend Per Share0.000.0%0.000.0%0.1246.1%0.1142.8%0.0521.4%
Usd Total Gains Per Share0.0310.6%0.0310.6%-0.04-17.2%0.0726.9%0.0416.4%
Usd Price Per Share0.20-0.20-0.00-0.05-0.04-
Price to Earnings Ratio-0.93--0.93--0.01--0.24--0.29-
Price-to-Total Gains Ratio7.38-7.38--0.08-1.88-0.72-
Price to Book Ratio-2.80--2.80--0.03--0.43--0.07-
Price-to-Total Gains Ratio7.38-7.38--0.08-1.88-0.72-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.162625
Number of shares6149
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.11
Usd Book Value Change Per Share0.03-0.04
Usd Total Gains Per Share0.030.07
Gains per Quarter (6149 shares)162.66412.84
Gains per Year (6149 shares)650.641,651.37
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
106516412631-9801641
20130112925263-19603292
30195219437894-29404943
402603259410526-39206594
503253324513157-49018245
603904389615789-58819896
704554454718420-686111547
805205519821052-784113198
905856584923683-882114849
1006506650026315-980116500

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.010.00.00.0%2.017.00.010.5%
Book Value Change Per Share1.00.00.0100.0%1.02.00.033.3%2.03.00.040.0%4.06.00.040.0%8.011.00.042.1%
Dividend per Share0.00.01.00.0%2.00.01.066.7%4.00.01.080.0%4.00.06.040.0%4.00.015.021.1%
Total Gains per Share1.00.00.0100.0%2.01.00.066.7%4.01.00.080.0%6.04.00.060.0%10.09.00.052.6%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Argent Biopharma Limited compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0410.0410%-0.243+699%-0.061+251%-0.019+147%
Book Value Per Share---0.107-0.1070%-0.148+38%0.030-453%0.113-195%
Current Ratio--0.2250.2250%0.190+19%0.777-71%1.296-83%
Debt To Asset Ratio--1.5401.5400%1.804-15%1.021+51%0.640+141%
Debt To Equity Ratio----0%-0%0.920-100%0.634-100%
Dividend Per Share----0%0.177-100%0.164-100%0.082-100%
Eps---0.323-0.3230%-0.384+19%-0.333+3%-0.231-29%
Free Cash Flow Per Share---0.265-0.2650%-0.224-15%-0.249-6%-0.168-37%
Free Cash Flow To Equity Per Share--0.0090.0090%-0.045+627%-0.021+351%-0.006+174%
Gross Profit Margin--1.0001.0000%1.045-4%1.032-3%1.036-3%
Intrinsic Value_10Y_max---1.177--------
Intrinsic Value_10Y_min---2.918--------
Intrinsic Value_1Y_max---0.157--------
Intrinsic Value_1Y_min---0.267--------
Intrinsic Value_3Y_max---0.442--------
Intrinsic Value_3Y_min---0.828--------
Intrinsic Value_5Y_max---0.692--------
Intrinsic Value_5Y_min---1.415--------
Market Cap13568075.000-20%16281690.00016281690.0000%271361.500+5900%4102985.880+297%3283474.150+396%
Net Profit Margin---19.673-19.6730%-6.147-69%-8.946-55%-360.434+1732%
Operating Margin----0%-4.5740%-3.2820%-267.8440%
Operating Ratio--0.7710.7710%5.574-86%4.236-82%359.122-100%
Pb Ratio-2.329+17%-2.795-2.7950%-0.034-99%-0.433-85%-0.072-97%
Pe Ratio-0.774+17%-0.929-0.9290%-0.013-99%-0.235-75%-0.291-69%
Price Per Share0.250-20%0.3000.3000%0.005+5900%0.076+297%0.061+396%
Price To Free Cash Flow Ratio-0.942+17%-1.131-1.1310%-0.022-98%-0.288-74%-0.465-59%
Price To Total Gains Ratio6.148-20%7.3777.3770%-0.075+101%1.880+293%0.722+922%
Quick Ratio--0.0120.0120%0.058-80%0.528-98%1.066-99%
Return On Assets---1.625-1.6250%-2.086+28%-1.581-3%-1.144-30%
Return On Equity----0%-0%-2.1740%-1.5460%
Total Gains Per Share--0.0410.0410%-0.066+263%0.103-61%0.063-36%
Usd Book Value---3789045.410-3789045.4100%-5224708.668+38%1072464.128-453%3979534.187-195%
Usd Book Value Change Per Share--0.0260.0260%-0.158+699%-0.040+251%-0.012+147%
Usd Book Value Per Share---0.070-0.0700%-0.096+38%0.020-453%0.073-195%
Usd Dividend Per Share----0%0.115-100%0.107-100%0.053-100%
Usd Eps---0.210-0.2100%-0.250+19%-0.217+3%-0.150-29%
Usd Free Cash Flow---9368327.967-9368327.9670%-7919867.423-15%-8803058.559-6%-5915062.526-37%
Usd Free Cash Flow Per Share---0.173-0.1730%-0.146-15%-0.162-6%-0.109-37%
Usd Free Cash Flow To Equity Per Share--0.0060.0060%-0.029+627%-0.014+351%-0.004+174%
Usd Market Cap8826032.788-20%10591239.34510591239.3450%176520.656+5900%2668992.315+297%2135899.935+396%
Usd Price Per Share0.163-20%0.1950.1950%0.003+5900%0.049+297%0.039+396%
Usd Profit---11403655.300-11403655.3000%-13545741.392+19%-12220903.169+7%-8540463.353-25%
Usd Revenue--579649.492579649.4920%2203612.334-74%1832573.378-68%986630.263-41%
Usd Total Gains Per Share--0.0260.0260%-0.043+263%0.067-61%0.041-36%
 EOD+1 -7MRQTTM+0 -0YOY+23 -105Y+16 -1810Y+14 -20

3.3 Fundamental Score

Let's check the fundamental score of Argent Biopharma Limited based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.774
Price to Book Ratio (EOD)Between0-1-2.329
Net Profit Margin (MRQ)Greater than0-19.673
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.012
Current Ratio (MRQ)Greater than10.225
Debt to Asset Ratio (MRQ)Less than11.540
Debt to Equity Ratio (MRQ)Less than10.000
Return on Equity (MRQ)Greater than0.150.000
Return on Assets (MRQ)Greater than0.05-1.625
Total1/10 (10.0%)

3.4 Technical Score

Let's check the technical score of Argent Biopharma Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5041.077
Ma 20Greater thanMa 500.270
Ma 50Greater thanMa 1000.345
Ma 100Greater thanMa 2000.324
OpenGreater thanClose0.260
Total2/5 (40.0%)

4. In-depth Analysis

4.1 About Argent Biopharma Limited

Argent BioPharma Limited, a multidisciplinary drug development Company, engages in the provision of medicines targeting immunology and neurology worldwide. The company's principal product candidates include CimetrA, which is in phase IIB clinical trial for the treatment of acute lung injury and ARDS; CannEpil, which is in phase I clinical trial for refractory epilepsy; and CogniCann, which is in phase IIA clinical trial for the symptomatic relief of Dementia and Alzheimer. It is also involved in the preclinical development of Irnican for the treatment of Glioblastoma Multiforme; and RGAI03MW01, which focuses on chronic wound treatment. The company was formerly known as MGC Pharmaceuticals Limited and changed its name to Argent BioPharma Limited. Argent BioPharma Limited was founded in 2014 and is based in Subiaco, Australia.

Fundamental data was last updated by Penke on 2024-11-14 22:54:03.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is unable to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is unable to pay all its debts by selling its assets.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is expensive.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profit Argent Biopharma Limited earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Argent Biopharma Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -1,967.3% means that $-19.67 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Argent Biopharma Limited:

  • The MRQ is -1,967.3%. The company is making a huge loss. -2
  • The TTM is -1,967.3%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-1,967.3%TTM-1,967.3%0.0%
TTM-1,967.3%YOY-614.7%-1,352.6%
TTM-1,967.3%5Y-894.6%-1,072.7%
5Y-894.6%10Y-36,043.4%+35,148.8%
4.3.1.2. Return on Assets

Shows how efficient Argent Biopharma Limited is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Argent Biopharma Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • -162.5% Return on Assets means that Argent Biopharma Limited generated $-1.63 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Argent Biopharma Limited:

  • The MRQ is -162.5%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -162.5%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-162.5%TTM-162.5%0.0%
TTM-162.5%YOY-208.6%+46.1%
TTM-162.5%5Y-158.1%-4.4%
5Y-158.1%10Y-114.4%-43.7%
4.3.1.3. Return on Equity

Shows how efficient Argent Biopharma Limited is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Argent Biopharma Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • 0.0% Return on Equity means Argent Biopharma Limited generated $0.00 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Argent Biopharma Limited:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-217.4%+217.4%
5Y-217.4%10Y-154.6%-62.8%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Argent Biopharma Limited.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

Measures how efficient Argent Biopharma Limited is operating .

  • Measures how much profit Argent Biopharma Limited makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Argent Biopharma Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Argent Biopharma Limited:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-457.4%+457.4%
TTM-5Y-328.2%+328.2%
5Y-328.2%10Y-26,784.4%+26,456.2%
4.3.2.2. Operating Ratio

Measures how efficient Argent Biopharma Limited is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 0.77 means that the operating costs are $0.77 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Argent Biopharma Limited:

  • The MRQ is 0.771. The company is efficient in keeping operating costs low. +1
  • The TTM is 0.771. The company is efficient in keeping operating costs low. +1
Trends
Current periodCompared to+/- 
MRQ0.771TTM0.7710.000
TTM0.771YOY5.574-4.802
TTM0.7715Y4.236-3.465
5Y4.23610Y359.122-354.885
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Argent Biopharma Limited.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Argent Biopharma Limited is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 0.23 means the company has $0.23 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Argent Biopharma Limited:

  • The MRQ is 0.225. The company is unable to pay all its short-term debts. -2
  • The TTM is 0.225. The company is unable to pay all its short-term debts. -2
Trends
Current periodCompared to+/- 
MRQ0.225TTM0.2250.000
TTM0.225YOY0.190+0.035
TTM0.2255Y0.777-0.552
5Y0.77710Y1.296-0.519
4.4.3.2. Quick Ratio

Measures if Argent Biopharma Limited is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Argent Biopharma Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 0.01 means the company can pay off $0.01 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Argent Biopharma Limited:

  • The MRQ is 0.012. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.012. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.012TTM0.0120.000
TTM0.012YOY0.058-0.046
TTM0.0125Y0.528-0.517
5Y0.52810Y1.066-0.538
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Argent Biopharma Limited.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much % of Argent Biopharma Limited assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Argent Biopharma Limited to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 1.54 means that Argent Biopharma Limited assets are financed with 154.0% credit (debt) and the remaining percentage (100% - 154.0%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Argent Biopharma Limited:

  • The MRQ is 1.540. The company is unable to pay all its debts by selling its assets. -2
  • The TTM is 1.540. The company is unable to pay all its debts by selling its assets. -2
Trends
Current periodCompared to+/- 
MRQ1.540TTM1.5400.000
TTM1.540YOY1.804-0.265
TTM1.5405Y1.021+0.519
5Y1.02110Y0.640+0.381
4.5.4.2. Debt to Equity Ratio

Measures if Argent Biopharma Limited is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Argent Biopharma Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 0.0% means that company has $0.00 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Argent Biopharma Limited:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y0.920-0.920
5Y0.92010Y0.634+0.287
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Argent Biopharma Limited generates.

  • Above 15 is considered overpriced but always compare Argent Biopharma Limited to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -0.93 means the investor is paying $-0.93 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Argent Biopharma Limited:

  • The EOD is -0.774. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.929. Based on the earnings, the company is expensive. -2
  • The TTM is -0.929. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.774MRQ-0.929+0.155
MRQ-0.929TTM-0.9290.000
TTM-0.929YOY-0.013-0.916
TTM-0.9295Y-0.235-0.694
5Y-0.23510Y-0.291+0.055
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Argent Biopharma Limited:

  • The EOD is -0.942. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.131. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -1.131. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.942MRQ-1.131+0.188
MRQ-1.131TTM-1.1310.000
TTM-1.131YOY-0.022-1.108
TTM-1.1315Y-0.288-0.842
5Y-0.28810Y-0.465+0.177
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price of Argent Biopharma Limited is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Argent Biopharma Limited:

  • The EOD is -2.329. Based on the equity, the company is expensive. -2
  • The MRQ is -2.795. Based on the equity, the company is expensive. -2
  • The TTM is -2.795. Based on the equity, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.329MRQ-2.795+0.466
MRQ-2.795TTM-2.7950.000
TTM-2.795YOY-0.034-2.761
TTM-2.7955Y-0.433-2.362
5Y-0.43310Y-0.072-0.361
4.6.2. Total Gains per Share

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Argent Biopharma Limited.

3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2020-06-302021-06-302022-06-302023-06-302024-06-30
Total Other Income Expense Net -7,3951,270-6,124-1,740-7,8642,226-5,6386,8321,194



5.2. Latest Balance Sheet

Balance Sheet of 2024-06-30. Currency in AUD. All numbers in thousands.

Summary
Total Assets10,787
Total Liabilities16,612
Total Stockholder Equity-5,152
 As reported
Total Liabilities 16,612
Total Stockholder Equity+ -5,152
Total Assets = 10,787

Assets

Total Assets10,787
Total Current Assets2,740
Long-term Assets8,047
Total Current Assets
Cash And Cash Equivalents 703
Net Receivables 140
Inventory 875
Total Current Assets  (as reported)2,740
Total Current Assets  (calculated)1,718
+/- 1,022
Long-term Assets
Property Plant Equipment 6,720
Long Term Investments 1,327
Long-term Assets  (as reported)8,047
Long-term Assets  (calculated)8,047
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities12,176
Long-term Liabilities4,436
Total Stockholder Equity-5,152
Total Current Liabilities
Accounts payable 957
Other Current Liabilities 8,680
Total Current Liabilities  (as reported)12,176
Total Current Liabilities  (calculated)9,636
+/- 2,540
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt1,045
Long-term Liabilities  (as reported)4,436
Long-term Liabilities  (calculated)1,045
+/- 3,391
Total Stockholder Equity
Total Stockholder Equity (as reported)-5,152
Total Stockholder Equity (calculated)0
+/- 5,152
Other
Capital Stock123,289
Common Stock Shares Outstanding 45,280
Net Invested Capital -5,152
Net Working Capital -9,436
Property Plant and Equipment Gross 10,845



5.3. Balance Sheets Structured

Currency in AUD. All numbers in thousands.

 Trend2024-06-302023-06-302022-06-302021-06-302020-06-302019-06-302018-06-302017-06-302016-06-302015-06-302014-06-302013-06-302012-06-302012-04-302011-06-302010-06-302009-06-302008-06-302007-06-302006-06-30
> Total Assets 
5,370
4,791
2,641
16,420
14,132
1,094
752
992
8,704
4,978
2,521
16,361
20,820
19,994
12,997
7,929
24,236
18,558
9,984
10,787
10,7879,98418,55824,2367,92912,99719,99420,82016,3612,5214,9788,7049927521,09414,13216,4202,6414,7915,370
   > Total Current Assets 
2,957
2,928
1,167
1,792
215
1,094
0
605
238
663
521
9,030
12,485
11,504
3,720
3,231
9,481
6,458
2,531
2,740
2,7402,5316,4589,4813,2313,72011,50412,4859,03052166323860501,0942151,7921,1672,9282,957
       Cash And Cash Equivalents 
2,755
1,143
636
890
59
1,071
713
516
161
595
437
7,896
11,364
9,859
2,354
1,873
5,433
1,886
240
703
7032401,8865,4331,8732,3549,85911,3647,8964375951615167131,071598906361,1432,755
       Net Receivables 
191
1,408
467
936
69
23
11
25
54
59
58
360
608
70
271
522
2,349
1,937
531
140
1405311,9372,34952227170608360585954251123699364671,408191
       Other Current Assets 
12
8
18
8
86
23
12
55
22
68
84
977
613
862
956
434
827
796
397
0
039779682743495686261397784682255122386818812
   > Long-term Assets 
2,413
1,864
1,474
14,628
13,917
0
0
388
8,466
4,315
2,000
7,295
8,335
8,490
9,277
4,698
14,754
12,100
7,453
8,047
8,0477,45312,10014,7544,6989,2778,4908,3357,2952,0004,3158,4663880013,91714,6281,4741,8642,413
       Property Plant Equipment 
150
166
160
152
0
0
0
0
8,466
4,315
2,000
211
1,258
1,334
1,470
4,024
7,141
8,798
7,453
6,720
6,7207,4538,7987,1414,0241,4701,3341,2582112,0004,3158,4660000152160166150
       Goodwill 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
7,049
7,049
3,146
0
0
003,1467,0497,049000000000000000
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
73
2,772
674
0
156
0
1,327
1,327015606742,772730000000000000
       Intangible Assets 
396
400
421
421
0
0
0
0
0
0
0
7,084
7,076
7,083
5,034
7,049
7,049
3,146
0
0
003,1467,0497,0495,0347,0837,0767,0840000000421421400396
       Long-term Assets Other 
1,862
1,025
893
277
4
0
0
388
-8,466
-4,315
-2,000
-7,295
-8,335
-8,490
-9,277
674
-14,754
-12,100
-7,453
0
0-7,453-12,100-14,754674-9,277-8,490-8,335-7,295-2,000-4,315-8,4663880042778931,0251,862
> Total Liabilities 
2,608
977
704
16,428
17,270
266
312
205
759
429
594
4,632
5,031
7,303
2,199
4,835
10,410
13,378
18,015
16,612
16,61218,01513,37810,4104,8352,1997,3035,0314,63259442975920531226617,27016,4287049772,608
   > Total Current Liabilities 
1,418
587
650
3,337
16,570
266
312
205
484
234
399
4,612
4,966
7,231
2,181
2,969
6,130
7,707
13,332
12,176
12,17613,3327,7076,1302,9692,1817,2314,9664,61239923448420531226616,5703,3376505871,418
       Short-term Debt 
1,293
338
36
1,450
13,893
38
0
0
131
195
195
1,075
20
22
588
54
4,244
2,378
9,370
0
09,3702,3784,2445458822201,075195195131003813,8931,450363381,293
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
195
195
1,075
20
22
0
0
4,691
2,100
0
0
002,1004,6910022201,075195195000000000
       Accounts payable 
67
385
591
1,627
373
150
0
0
116
93
369
145
465
809
1,165
2,004
1,222
2,524
2,186
957
9572,1862,5241,2222,0041,16580946514536993116001503731,62759138567
       Other Current Liabilities 
58
26
35
40
32
78
312
205
236
141
30
4,466
4,501
6,422
1,017
811
664
996
1,118
8,680
8,6801,1189966648111,0176,4224,5014,46630141236205312783240352658
   > Long-term Liabilities 
1,190
390
54
13,091
700
0
0
0
275
195
195
20
20
22
17
1,865
4,280
5,671
4,683
4,436
4,4364,6835,6714,2801,8651722202019519527500070013,091543901,190
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
195
20
20
22
0
1,845
1,773
2,143
385
0
03852,1431,7731,84502220201950000000000
       Long term Debt 
1,061
390
54
13,091
700
0
0
0
275
195
195
20
20
22
0
0
0
0
0
0
00000022202019519527500070013,091543901,061
       Capital Lease Obligations 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,899
1,983
2,294
575
1,045
1,0455752,2941,9831,899000000000000000
       Other Liabilities 
0
0
0
0
0
0
0
0
0
0
0
0
45
51
17
20
2,506
2,382
4,299
0
04,2992,3822,50620175145000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
-81
-400
0
0
0
0
15
0
0
00150000-400-8100000000000
> Total Stockholder Equity
2,762
3,814
1,937
-9
-2,589
828
440
787
7,945
4,549
1,927
11,810
16,233
13,933
10,959
3,105
13,835
5,837
-7,403
-5,152
-5,152-7,4035,83713,8353,10510,95913,93316,23311,8101,9274,5497,945787440828-2,589-91,9373,8142,762
   Common Stock
2,637
3,568
3,973
3,982
4,032
5,515
5,515
5,765
14,046
15,701
16,501
32,343
42,557
48,441
49,134
60,149
84,512
97,251
103,691
0
0103,69197,25184,51260,14949,13448,44142,55732,34316,50115,70114,0465,7655,5155,5154,0323,9823,9733,5682,637
   Retained Earnings 
125
44
-2,036
-3,991
-6,621
-4,686
0
-4,977
-6,347
-11,685
-15,482
-21,640
-29,784
-38,030
-42,765
-62,128
-77,998
-98,345
-119,169
-129,668
-129,668-119,169-98,345-77,998-62,128-42,765-38,030-29,784-21,640-15,482-11,685-6,347-4,9770-4,686-6,621-3,991-2,03644125
   Capital Surplus 00000000000000000000
   Treasury Stock00000000000000000000
   Other Stockholders Equity 
0
202
0
0
0
0
0
0
0
533
25
0
0
0
4,590
5,084
-6,514
0
212
0
02120-6,5145,0844,5900002553300000002020



5.4. Balance Sheets

Currency in AUD. All numbers in thousands.




5.5. Cash Flows

Currency in AUD. All numbers in thousands.




5.6. Income Statements

Currency in AUD. All numbers in thousands.


5.7. Latest Income Statement

Income Statement (annual), 2024-06-30. Currency in AUD. All numbers in thousands.

Gross Profit (+$)
totalRevenue891
Cost of Revenue-687
Gross Profit204204
 
Operating Income (+$)
Gross Profit204
Operating Expense-0
Operating Income-18,262204
 
Operating Expense (+$)
Research Development2,321
Selling General Administrative11,085
Selling And Marketing Expenses0
Operating Expense013,406
 
Net Interest Income (+$)
Interest Income2
Interest Expense-482
Other Finance Cost-0
Net Interest Income-481
 
Pretax Income (+$)
Operating Income-18,262
Net Interest Income-481
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-17,548-19,456
EBIT - interestExpense = -482
-17,531
-17,048
Interest Expense482
Earnings Before Interest and Taxes (EBIT)0-17,066
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-17,548
Tax Provision-0
Net Income From Continuing Ops-17,548-17,548
Net Income-17,531
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net1,194481
 

Technical Analysis of Argent Biopharma Limited
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Argent Biopharma Limited. The general trend of Argent Biopharma Limited is BEARISH with 85.7% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Argent Biopharma Limited's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-85.7%) Bearish trend (85.7%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Argent Biopharma Limited.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 0.25 < 0.295 < 0.295.

The bearish price targets are: 0.15.

Tweet this
Argent Biopharma Limited Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Argent Biopharma Limited. The current mas is .

The long score for the Moving Averages is 1/14.
The longshort score for the Moving Averages is -12/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Argent Biopharma Limited Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Argent Biopharma Limited. The current macd is -0.02633237.

The long score for the Moving Average Convergence/Divergence (MACD) is 3/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is 2/(-4 +4).

  • MACD line > signal line: The MACD line is above the signal line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Argent Biopharma Limited price going up in the near term. +2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Argent Biopharma Limited. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Argent Biopharma Limited price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Argent Biopharma Limited Daily Moving Average Convergence/Divergence (MACD) ChartArgent Biopharma Limited Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Argent Biopharma Limited. The current adx is 31.37.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -3/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Argent Biopharma Limited shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending down: The ADX is above 25 and indicates a strong bearish trend. The ADX is declining, the bearish trend is weakening. Could be a potential reversal to the upside. -2
Argent Biopharma Limited Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Argent Biopharma Limited. The current sar is 0.28444311.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Argent Biopharma Limited Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Argent Biopharma Limited. The current rsi is 41.08. The current phase is Continuation in bear market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -3/(-13 +13).

  • Continuation in bear market: Downtrend continues after a consolidation or pullback. Hold or add to short positions.
Argent Biopharma Limited Daily Relative Strength Index (RSI) ChartArgent Biopharma Limited Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Argent Biopharma Limited. The current phase is Continuation in bear market.

The long score for the Stochastic Oscillator is 2/6.
The longshort score for the Stochastic Oscillator is 0/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Argent Biopharma Limited price going up in the near term. +2
  • Trending down: The STOCH %K is trending down. -1
Argent Biopharma Limited Daily Stochastic Oscillator ChartArgent Biopharma Limited Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Argent Biopharma Limited. The current cci is -63.44605475.

Argent Biopharma Limited Daily Commodity Channel Index (CCI) ChartArgent Biopharma Limited Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Argent Biopharma Limited. The current cmo is -16.93798093.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Argent Biopharma Limited Daily Chande Momentum Oscillator (CMO) ChartArgent Biopharma Limited Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Argent Biopharma Limited. The current willr is -69.23076923.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Argent Biopharma Limited is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Argent Biopharma Limited Daily Williams %R ChartArgent Biopharma Limited Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Argent Biopharma Limited.

Argent Biopharma Limited Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Argent Biopharma Limited. The current atr is 0.0218162.

Argent Biopharma Limited Daily Average True Range (ATR) ChartArgent Biopharma Limited Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Argent Biopharma Limited. The current obv is -460,198.

Argent Biopharma Limited Daily On-Balance Volume (OBV) ChartArgent Biopharma Limited Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Argent Biopharma Limited. The current mfi is 42.86.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Argent Biopharma Limited Daily Money Flow Index (MFI) ChartArgent Biopharma Limited Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Argent Biopharma Limited.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-07-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-17WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-18STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-22CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-07-23DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-07-24SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-07-25WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-07-26CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-07-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-07-31MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-08-01MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-06DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-07MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-08MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-12MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-08-13MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-08-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-08-16RSI LONG ENTRY SHORT CLOSE30 crossover to upside
STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-08-22STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-08-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-08-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-08-30CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-02STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-09-10STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-09-11MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-09-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-13CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-09-16STOCH LONG EXITThe %K line crosses below the %D line.
2024-09-17CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-18CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-09-23CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-09-24MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-09-25STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-09-26CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-09-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-09-30STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-01STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2024-10-03STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2024-10-04STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-07RSI SHORT ENTRY LONG CLOSE70 crossover to downside
STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-08STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-10-09RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-10-10STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-14MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-10-16STOCH SHORT EXITThe %K line crosses above the %D line.
2024-10-17STOCH LONG EXITThe %K line crosses below the %D line.
2024-10-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-10-22MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-10-24CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-11-04CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-11-06STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-07STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-08MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-11-11STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-11-12STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-11-13MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2024-11-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-11-18CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-11-21MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-11-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-11-26STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-11-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.

6.3. Candlestick Patterns

Argent Biopharma Limited Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Argent Biopharma Limited based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5041.077
Ma 20Greater thanMa 500.270
Ma 50Greater thanMa 1000.345
Ma 100Greater thanMa 2000.324
OpenGreater thanClose0.260
Total2/5 (40.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Argent Biopharma Limited with someone you think should read this too:
  • Are you bullish or bearish on Argent Biopharma Limited? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Argent Biopharma Limited? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Argent Biopharma Limited

I send you an email if I find something interesting about Argent Biopharma Limited.


Comments

How you think about this?

Leave a comment

Stay informed about Argent Biopharma Limited.

Receive notifications about Argent Biopharma Limited in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.